Latest

• Practical guidelines for antibiotic prescribing in breast surgery: antibiotic prophylaxis and treatment of surgical site infections and implant-associated infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(3):244-273

• Antimicrobial susceptibility of Moraxella catarrhalis in Russia: results of the PEGAS 2010–2021 multicenter study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(2):188-193

• Piperacillin-tazobactam in the treatment of severe intra-abdominal and urinary tract infections in the Russian Federation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(2):171-187

• Antimicrobial resistance of clinical isolates of Klebsiella pneumoniae and Escherichia coli in Russian hospitals: results of a multicenter epidemiological study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(1):67-78

• Ceftaroline fosamil – fifth-generation cephalosporin with anti-MRSA activity in the treatment of severe infections in pediatric practice

  Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(1):40-58

• Antimicrobial drug consumption in the Russian Federation (2008–2022): pharmacoepidemiological study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(4):395-400

• In vitro activity of cefpodoxime against Russian clinical isolates of Haemophilus influenzae, Streptococcus pneumoniae and Streptococcus pyogenes

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(4):372-378

• Cefpodoxime proxetil – new opportunities in antibacterial therapy of respiratory infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(4):366-371

• Patterns of antibiotic use in the population of various regions of the Russian Feder ation: a qualitative, comparative analysis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):247-259

• Microbiologic diagnosis of community-acquired urinary tract infections: official statements of the board of experts

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):221-224

• Systemic analysis of the AST results in medical organizations of the Russian Feder ation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(2):179-186

• Point prevalence multicenter survey of antimicrobial consumption in Russian hospitals: results of the Global-PPS 2021

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(2):150-158

• Patterns of antimicrobial dispensing in community pharmacies in Russia during the COVID-19 pandemic

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):84-92

• Consumption of systemic antibiotics in the Russian Federation in 2017–2021

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(3):220-225

• Monitoring of macrolide resistanceassociated mutations in Mycoplasma genitalium in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(1):52-60

• Practice of local antibiotic resistance monitoring at hospitals in various regions of the Russian Federation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(1):31-38

• In vitro activity of biapenem and other carbapenems against Russian clinical isolates of Pseudomonas aeruginosa, Acinetobacter spp., and Enterobacterales

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):280-291

• Susceptibility of clinical Enterobacterales and Pseudomonas aeruginosa isolates to ceftazidimeavibactam in Russia: multicenter local laboratory databased surveillance

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):264-278

• AMRmap – antibiotic resistance surveillance system in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):198-204

• Official statements of the board of experts on the use of topical thiamphenicol in patients with communityacquired respiratory infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):195-196

• Official statements of the expert meeting on pneumococcal vaccination in adults in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):161-165

• The prevalence and antimicrobial susceptibility of circulating S. pneumoniae serotypes in adult population in Russia (epidemiological study «SPECTRUM»)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):127-137

• In vitro activity of thiamphenicol against Haemophilus influenzae, Streptococcus pneumoniae and Streptococcus pyogenes clinical isolates

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(1):92-99

• War and Peace: the difficult treatment of urinary tract infections and fosfomycin trometamol

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(1):44-53

• Effect of 23S rRNA gene mutations in Mycoplasma pneumoniae on severity of communityacquired pneumonia in young adult patients treated at the Smolensk militar y hospital

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(4):306-312

• Pneumococcal vaccination in adult patients with comorbidities: a review of the clinical practice guidelines

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(4):254-265

• Nasopharyngeal carriage of Streptococcus pneumoniae in children from day-care centers in Smolensk

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):149-153

• Results of an open-label, randomized, comparative clinical trial of nifuratel in the eradication of Helicobacter pylori infection in adult patients

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):119-127

• Antimicrobial resistance of clinical Streptococcus pyogenes isolates in Russia: the results of multicenter epidemiological study «PEHASus 2014–2017»

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):40-45

• Doxycycline in the current clinical practice

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):21-28

• Antimicrobial resistance of Haemophilus influenzae clinical isolates in Russia: the results of multicenter epidemiological study «PEHASus 2014–2017»

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(4):317-323

• To stop the progress of antimicrobial resistance today means to give a chance of mankind surviving tomorrow

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(4):310-315

• The prevalence of circulating S. pneumoniae serotypes in people older than 18 years: healthy carriers, patients with acute otitis media, community-acquired pneumonia, and invasive pneumococcal infections (epidemiological study «SPECTRUM»)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(4):275-281

• Antimicrobial resistance of clinical Streptococcus pneumoniae isolates in Russia: the results of multicenter epidemiological study «PEHASus 2014–2017»

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):230-237

• Oral third-generation cephalosporins in the treatment of community-acquired urinary tract infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):225-228

• Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Acinetobacter spp. isolates in Russia: results of multicenter epidemiological study ”MARATHON 2015–2016”

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):171-180

• Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):160-170

• Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):147-159

• Antimicrobial resistance of pathogens causing community-acquired urinary tract infections in Russia: results of the multicenter study “DARMIS-2018”

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):134-146

• AMRcloud: a new paradigm in monitoring of antibiotic resistance

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):119-124

• Antimicrobal resistance of nosocomial carbapenemase-producing Enterobacterales in Russia: results of surveillance, 2014-2016

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):362-369

• Ceftolozane/tazobactam – the «new player» in a battle against multiresistant pathogens

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):354-361

• Safety and efficacy of nemonoxacin versus levofloxacin in the treatment of community-acquired pneumonia: results of phase III, multicenter, randomized, double-blind, active-controlled, non-inferiority trial

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):341-353

• Comparison of in vitro activity of various macrolides against Helicobacter pylori

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):192-197

• Pseudomonas aeruginosa: the history of one of the most successful nosocomial pathogens in Russian hospitals

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(3):164-171

• Review of updated clinical practice guidelines of the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) for Clostridium difficile infection in adults and children (2017)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(2):76-124

• Susceptibility testing of Candida glabrata clinical strains to echinocandins using SensititreTM YeastOneTM system

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):49-54

• Antimicrobial resistance of Helicobacter pylori in Smolensk

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):42-48

• Ceftazidime-avibactam: new rules for the game against multidrug-resistant gram-negative bacteria

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):24-34

• Vaccination against pneumococcal infections in adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):5-8

• Four cases of resistance mutations in 23S rRNA gene in Mycoplasma pneumoniae isolated from the hospitalized military personnel

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(3):248-253

• Antibiotic dosing in obesity: size does matter?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(3):214-228

• Epidemiology of S. pneumoniae serotypes in the Russian Federation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(3):200-206

• Antimicrobial resistance and clonal evolution of Streptococcus pneumoniae serotype 19A in Russia during 2002-2013

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(2):145-151

• Study to assess incidence of acute otitis media in children under 5 years of age in Russia (PAPIRUS-AOM)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(2):116-120

• AMRmap: an online platform for monitoring antibiotic resistance

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(2):84-90

• Antimicrobial resistance of nosocomial Staphylococcus aureus isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(1):57-62

• Antimicrobial resistance of nosocomial Enterobacteriaceae isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(1):49-56

• Antimicrobial resistance of nosocomial Acinetobacter spp. isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(1):42-48

• Antimicrobial resistance of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(1):37-41

• Responsible Use of Antibiotics in Food Animals

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(3):186-190

• Potential of the Introduction of Tedizolid for the Treatment of Complicated Skin and Soft Tissue Infections in a Russian Multi-Field Hospital

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(3):174-185

• A Novel View on Common Antibiotics: How to Properly Use Pharmacodynamic Parameters

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(2):125-129

• A Retrospective Data Analysis of the Structure of Isolated Microorganisms in Secondary Skin and Soft Tissue Infections Using Permuted Test

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(1):33-41

• Paediatricians Approach to Prescribing of Systemic Antimicrobials in Outpatient Children with Upper Respiratory Tract and ENT Infections: Data from Multicenter Survey

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(1):20-32

• Antimicrobial Resistance of Gram-negative Microorganisms Causing Complicated Intra-abdominal Infections in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(3):227-234

• In vitro Ceftaroline Activity against Major Bacterial Pathogens n Russia: Results of Multicenter Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(3):217-226

• Telavancin — New Antimicrobial Active Against Multiresistant Gram-Positive Pathogens. Clinical and Microbiological Features in Questions and Answers

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(2):127-145

• Clinical Guidelines on Diagnosis, Treatment and Prophylaxis of Severe Community-Acquired Pneumonia in Adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(2):84-126

• Clinico-Economic Effectiveness of Ceftaroline Fosamil for the Treatment of Hospitalised Patients with Pneumococcal Community-Acquired Pneumonia from a Societal Perspective

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(1):33-51

• Etiology of Infective Endocarditis in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(1):4-10

• Systemic Antimicrobials Consumption and Expenditures in Intensive Care Units of Hospitals in Russian Federation and Republic of Belarus: Results of Multicenter Pharmacoepidemiological Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):294-311

• Evaluation of Prevalence of Classical Fluoroquinolone Resistance Mechanisms in Chlamydia trachomatis Due to Mutations in the Topoisomerase Genes

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):287-293

• Antimicrobial Resistance of Nosocomial Staphylococcus aureus Isolates in Russia: Results of National Multicenter Surveillance Study «MARATHON» 2011–2012

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):280-286

• Antimicrobial Resistance of Nosocomial Pseudomonas aeruginosa Isolates in Russia: Results of National Multicenter Surveillance Study «MARATHON» 2011–2012

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):273-279

• Antimicrobial Resistance of Nosocomial Acinetobacter spp. Isolates in Russia: Results of National Multicenter Surveillance Study «MARATHON» 2011–2012

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):266-272

• Antimicrobial Resistance of Nosocomial Enterobacteriaceae Isolates in Russia: Results of National Multicenter Surveillance Study «MARATHON» 2011–2012

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):254-265

• Susceptibility of Streptococcus pyogenes Clinical Strains to Hexetidine and to Systemic Antimicrobals

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(3):212-218

• Cefditoren Pivoxil: Clinical, Pharmacological, and Microbiological Aspects

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(2):111-129

• Antimicrobial Resistance of Haemophilus influenzae in Russia: Results of Multicenter Study «PeGASus»

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(1):57-69

• Complicated Community-Acquired Urinary Tract Infections in Adult Patients in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(1):33-38

• Choice of Antimicrobial Agents in Uncomplicated Urinary Tract Infections: How to Make Decision Worthy of Solomon?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(1):18-25

• Analysis of Antibiotic Usage in Children Living in Orphanages During the 2003–2004 and 2009–2010

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(4):286-294

• Incidence of Community-Acquired Pneumonia and Acute Otitis Media in Children 0–5 Years in Russia and Role of S. pneumoniae or H. influenzae in the Etiology of the Diseases

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(4):246-260

• Treatment of Acute Tonsillitis/Pharyngitis: Current Guidelines and Russian Local Situation

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(3):198-211

• Comparative Efficacy of Topical Combination of Bacitracin and Neomycin vs. Chloramphenicol in the Treatment of Uncomplicated Mild to Moderate Surgical Skin and Soft Tissue Infections in Adult Out-patients

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):131-142

• Ceftaroline – «Sui Generis»

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(2):124-130

• Community-Acquired Pneumonia Caused by Mycoplasma pneumoniae: Literature Review and Results of the Regional Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(1):4-13

• Systemic Antimicrobials Consumption and Expenditures in Multi-Profile Hospitals in Russian Federation and Republic of Belarus: the Results of Multicenter Pharmacoepidemiological Trial

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(4):322-341

• Antimicrobial Resistance of the Respiratory Strains of Streptococcus pyogenes in Russia During 1999–2009

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(4):309-321

• Current State of Antibiotic Resistance of Pathogens Causing Community-Acquired Urinary Tract Infections in Russia: «DARMIS» Study (2010–2011)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(4):280-302

• Antimicrobial Susceptibility of Bacterial Strains Contained in the Probiotic Preparation «Linex»

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(3):245-251

• Comparative Clinical and Pharmacoeconomic Analysis of Different Antimicrobial Treatment Regimens in Hospitalized Patients with Community-Acquired Pneumonia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(3):209-221

• Independent Acquisition of Quinolone Resistance in Clonally Related Nosocomial Strains of Salmonella Typhimurium Due to Hypermutability

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):153-161

• Prevalence and Molecular Epidemiology of Gram-negative Bacteria Producing Metallo-β-lactamases (MBLs) in Russia, Belarus and Kazakhstan

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(2):132-152

• Clonal dissemination of CTX-M-5-producing nosocomial strains of Salmonella Typhimurium in Russia, Belarus, and Kazakhstan

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(1):38-50

• Comparative Quality of Parenteral Formulations of Azithromycin Original and Generic Products

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(4):335-345

• Antimicrobial Stewardship as a Renascence of the ‘Golden Age’ of Antibiotics

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(4):322-334

• PCR-based Identification and Serotyping of Russian Streptococcus pneumoniae Strains

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(4):304-313

• Serological Characteristics and Antimicrobial Susceptibility of Streptococcus pneumoniae Isolated from Children 0–5 Years of Age in Different Regions of Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(2):177-187

• Antimicrobial Therapy of Complicated Intra-abdominal Infections: What are the Success Determinants?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(2):158-162

• Safety and Efficacy of Antibiotics Used in Outpatient Setting

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(1):67-84

• Antimicrobial Resistance of Streptococcus pneumoniae in Russia over the 1999–2009: Results of Multicenter Prospective Study PEHASus

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):329-341

• Selection of Resistance Associated with the Use of Antimicrobial Agents: Collateral Damage Concept

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(4):284-294

• Diagnosis and Management of Bacterial Sexually Transmitted Diseases in Russia: Results of Multicenter Pharmacoepidemiological Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(3):226-245

• Community-Acquired Pneumonia in Adults: Guidelines on the Diagnosis, Treatment and Prevention

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(3):186-125

• Ciprofloxacin in Current Clinical Practice

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):154-162

• Clinical Perspectives of Tigecycline

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(2):127-145

• To the Question of Interchangeability of Original and Generic Parenteral Antimicrobials

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):31-40

• Catheter-related Bloodstream Infections: Prevention or Treatment?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):23-30

• Potential for Use of Spiramycin in Clinical Practice

  Клиническая Микробиология и Антимикробная Химиотерапия. 2009; 11(3):218-238

• Patterns of Antibacterial Therapy of Community-Acquired Pneumonia in Hospitalized Adults in Different Regions of Russia: Lessons from Multicentre Pharmacoepidemiology Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(1):66-78

• Ertapenem – a Newer Carbapenem

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(1):40-55

• Guidelines on Diagnosis and Treatment of Legionella pneumophila Serogroup 1 Infection

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(1):4-13

• In Vitro Activity of Fluconazole and Voriconazole Against More Than 10000 Yeast Strains: Results of 5-years Prospective ARTEMIS Disk Study in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):345-354

• Epidemiology of Antimicrobial Resistance of S. aureus Isolated from ICU Patients in Russia: Results of Prospective Multicenter Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):333-344

• Meropenem in the Treatment of Severe Infections in Children

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):322-332

• Epidemiology of Antimicrobial Resistance of S. aureus Isolated from ICU Patients in Russia: Results of Prospective Multicenter Study

  Клиническая Микробиология и Антимикробная Химиотерапия. 2008; 10(3):290-301

• Doripenem: a New Carbapenem Antimicrobial

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(3):245-259

• Antimicrobial Resistance Patterns of Gram-negative Nosocomial Pathogens in Russian ICUs

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(2):163-179

• Nosocomial Pneumonia: Current State of Epidemiology, Diagnostics and Treatment

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(2):143-153

• Acute Bacterial Rhinosinusitis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(1):43-54

• Problems of Epidemiological Studies of Nosocomial Infections in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(1):4-14

• Antimicrobial Prophylaxis in Colorectal Surgery

  Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(3):244-252

• Streptococcus pyogenes: Characteristics of the Pathogen, Isolation, Identification and Susceptibility Testing

  Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(2):104-120

• Ceftibuten: Current Role in the Therapy of Infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):368-382

• Infectious Complications of the Anti-TNF Therapy: «Praemonitus, Praemunitus»

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):314-324

• Amoxicillin/Sulbactam – a New Beta-Lactam/Beta-Lactamase Inhibitor Combination

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(2):173-185

• Community-Acquired Pneumonia in Adults: Guidelines on Diagnosis, Treatment and Prophylaxis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(1):54-86

• Antimicrobial Resistance of Streptococcus pneumoniae in Russia in 1999–2005: Results of Multicentre Prospective Studies PEHASus-I and PEHASus-II

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(1):33-47

• Azithromycin: Current Clinical Use

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(1):18-32

• Clarithromycin: is There Potential for Clinical Use in the 21th Century?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(4):369-392

• Antimicrobial Resistance of Streptococcus pyogenes in Different Regions of Russia: Results of Multicentre Prospective Study PeHAS-I

  Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(2):154-166

• Efficacy of Cefoperazone/sulbactam in the Therapy of Bacterial Sepsis: Results of a Multicentre Study «IRIS»

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):318-328

• Community – Acquired Pneumonia: Giudelines on Diagnosis, Treatment and Prophylaxis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(3):198-224

• Antimicrobial Resistance of Streptococcus Pneumoniae in Different Regions of Russia: Results of Prospective Multicentre Study (phase А of project PeHAS-I)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(3):267-277

• Current Possibilities of Specific Prophylaxis of Pneumococcal Infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):61-69

• Rapid Phenotypic Methods for the Detection of Diphtheria Toxin Amongst Clinical Isolates of Corynebacteria

  Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):156-162

• Nosocomial Infections: Epydemiology, Pathogenesis, Prevention and Control

  Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(1):16-30

• Susceptibility to antimicrobials of pneumococci isolated from healthy children from organised collectives

  Clinical Microbiology and Antimicrobial Chemotherapy. 1999; 1(1):31-39